Managing acute bacterial skin and skin structure infections: Focus on new lipoglycopeptides

    loading  Checking for direct PDF access through Ovid

Abstract

Acute bacterial skin and skin structure infections (ABSSSI) are some of the most commonly encountered infections worldwide. Hospitalizations as a result of ABSSSI are associated with high mortality. This article discusses the role of oritavancin and dalbavancin, two new lipoglycopeptides, in the context of the other I.V. available standard therapy options.

    loading  Loading Related Articles